Loading...
Aurora Spine Corporation
ASAPF•PNK
Healthcare
Medical - Devices
$0.25
$0.00(0.00%)
Aurora Spine Corporation (ASAPF) Financial Performance & Income Statement Overview
Review Aurora Spine Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
20.95%
↑ 20.95%
Operating Income Growth
-51.05%
↓ 51.05%
Net Income Growth
40.34%
↑ 40.34%
Operating Cash Flow Growth
196.71%
↑ 196.71%
Operating Margin
-4.23%
↓ 4.23%
Gross Margin
50.77%
↑ 50.77%
Net Profit Margin
-5.98%
↓ 5.98%
ROE
-23.11%
↓ 23.11%
ROIC
-10.07%
↓ 10.07%
Aurora Spine Corporation (ASAPF) Income Statement & Financial Overview
Review Aurora Spine Corporation's (ASAPF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $4.70M | $4.77M | $4.08M | $4.01M |
| Cost of Revenue | $1.98M | $1.88M | $1.53M | $1.53M |
| Gross Profit | $2.72M | $2.88M | $2.55M | $2.48M |
| Gross Profit Ratio | $0.58 | $0.60 | $0.62 | $0.62 |
| R&D Expenses | $241639.00 | $139565.00 | $169003.00 | $181076.00 |
| SG&A Expenses | $2.67M | $2.39M | $2.28M | $2.23M |
| Operating Expenses | $3.17M | $2.77M | $2.66M | $2.71M |
| Total Costs & Expenses | $5.16M | $4.65M | $4.19M | $4.24M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $44666.00 | $43348.00 | $42468.00 | $44603.00 |
| Depreciation & Amortization | $260803.00 | $237273.00 | $210620.00 | $298729.00 |
| EBITDA | -$347229.00 | $351742.00 | $98980.00 | $76407.00 |
| EBITDA Ratio | -$0.07 | $0.07 | $0.02 | $0.02 |
| Operating Income | -$454489.00 | $114468.00 | -$111640.00 | -$222322.00 |
| Operating Income Ratio | -$0.10 | $0.02 | -$0.03 | -$0.06 |
| Other Income/Expenses (Net) | -$198209.00 | -$43348.00 | -$154108.00 | -$266925.00 |
| Income Before Tax | -$652698.00 | $71120.00 | -$154108.00 | -$266925.00 |
| Income Before Tax Ratio | -$0.14 | $0.01 | -$0.04 | -$0.07 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $255453.00 |
| Net Income | -$652698.00 | $71120.00 | -$154108.00 | -$266925.00 |
| Net Income Ratio | -$0.14 | $0.01 | -$0.04 | -$0.07 |
| EPS | -$0.01 | $0.001 | -$0.002 | -$0.003 |
| Diluted EPS | -$0.01 | $0.001 | -$0.002 | -$0.003 |
| Weighted Avg Shares Outstanding | $77.59M | $77.42M | $77.42M | $77.42M |
| Weighted Avg Shares Outstanding (Diluted) | $77.59M | $77.42M | $77.42M | $77.42M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan